TSC2 and tuberous sclerosis: In patients with tuberous sclerosis, the tuberin-hamartin complex-mediated inhibition of cell size and proliferation is relieved by the activation of phosphatidylinositol 3-kinase (PI3k) and Akt after stimulation of the insulin-like growth factor receptor.